General Anesthesia Drugs Market Sales, Size, Share and Demand Forecast 2032

General Anesthesia Drugs Market Size- By Drug Type, By Route of Administration, By Surgery Type, By End User- Regional Outlook, Competitive Strategies and Segment Forecasts to 2032

Published: Nov 2022 Base Year: 2021 Report ID: PHAR2211
Available Format: Historical Data: 2019 - 2020 Number of Pages: 1 - 230
Category : Pharmaceutical
Global General Anesthesia Drug  Market Overview:

According to SPER Market Research, the Global General Anesthesia Drug Market is estimated to reach USD 3.09 billion by 2032 with a CAGR of 3.7%. 

The purpose of a general anesthetic is to induce and maintain an unconscious state without any pain perception. Essentially, it is an intentionally inflicted state of unconsciousness coupled with a partial or whole absence of protective reflexes.



Impact of COVID-19 on the Global General Anesthesia Drug  Market  
In 2020, fewer surgeries were performed or postponed because of a modest decline in demand for anesthetic medicines brought on by the pandemic crisis. Approximately 28.4 million elective procedures are expected to be postponed or canceled worldwide, according to a study published in the British Journal of Surgery in May 2020. This estimate was based on a 12-week period during which COVID-19 caused the most severe disruption to hospital services. But as things get back to normal, all of the delayed elective procedures are now being finished, which leads to a rise in the number of anesthetic drugs taken.



Scope of the Report:
 Report Metric Details
 Market size available for years 2019-2032
 Base year considered 2021
 Forecast period 2022-2032
 Segments coveredBy Drug Type, By Route of Administration, By Surgery Type, By End User.
 Geographies coveredNorth America, Europe, Asia Pacific, Latin America, Middle East and Africa
 Companies CoveredAbbott Laboratories, Abbvie, Akorn, Apotex, Astra Zeneca Plc, Baxter International Inc., Bayer AG, F. Hoffmann- La Roche, Fresenius Se & Co KgaA, Gilead Science Inc., Galxo SmithKline Plc, Heritage Pharmaceutical  Inc., Hikma Pharmaceuticals Plc, Merck & Co Inc., Novarits AG, Par Pharmaceuticals, Pfizer Inc., Piramal Enterprises Ltd., Sanofi, Teva Pharmaceuticals.
Global General Anesthesia Drug  Market Segmentation:

By Drug Type: Based on the Drug Type, Global General Anesthesia Drug Market is segmented as: Propofol, Sevoflurane, Desflurane, Others.

By Route of Administartion: Based on the Route of Administration, Global General Anesthesia Drug Market is segmented as: Inhalation, Intravenous.

By Surgery Type: Based on the Surgery Type, Global General Anesthesia Drug Market is segmented as: Knee and Hip Replacements, Heart Surgery, Cancer Surgery, General Surgery.

By End User: 
Based on the End User, Global General Anesthesia Drug Market is segmented as: Hospitals, Ambulatory Surgical Centres.

By Region: North America owns the prime share of this market; the major factors of the market's growth in the region are the increasing incidence of chronic illnesses, the growing amount of medicine prescriptions brought on by the region's rapidly aging population, and the expansion of key market participants in the area.
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology
2.1 Research data source
2.1.1 Secondary data
2.1.2 Primary data
2.1.3 SPER’s internal database
2.1.4 Premium insight from KOL’s
2.2 Market size estimation
2.2.1 Top-down and Bottom-up approach
2.3 Data triangulation

3. Executive Summary

4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges 
4.2. COVID-19 Impacts of the Global Programmatic Advertising Market 

5. Market variables and outlook
5.1. SWOT analysis 
5.1.1 Strengths 
5.1.2 Weaknesses 
5.1.3 Opportunities
5.1.4 Threats
5.2. PESTEL analysis 
5.2.1 Political landscape
5.2.2 Economic landscape
5.2.3 Social landscape 
5.2.4 Technological landscape 
5.2.5 Environmental landscape 
5.2.6 Legal landscape 
5.3. PORTER’S five forces analysis 
5.3.1 Bargaining power of suppliers 
5.3.2 Bargaining power of Buyers 
5.3.3 Threat of Substitute 
5.3.4 Threat of new entrant 
5.3.5 Competitive rivalry
5.4. Heat map analysis

6. Global Programmatic Advertising Market, By Media Type, 2019-2032 (USD Million)
6.1 Audio Ads
6.2 DOOH
6.3 Digital Display
6.4 Social Ads
6.5 Video Ads

7. Global Programmatic Advertising Market, By Device, 2019-2032 (USD Million)
7.1  Mobile
7.2  Desktop

8. Global Programmatic Advertising Market, By Enterprise Size, 2019-2032 (USD Million)
8.1 SMBs
8.2 Large Enterprises

9. Global Programmatic Advertising Market, By End User, 2019-2032 (USD Million)
9.1 Education
9.2 Media and Entertainment
9.3 Retail
9.4 Travel

10. Global Programmatic Advertising Market, By Region, 2019-2032 (USD Million)
10.1 North America
10.1.1. United States
10.1.2. Canada
10.1.3. Mexico

10.2 Europe
10.2.1. Germany
10.2.2. United Kingdom
10.2.3. France
10.2.4. Italy
10.2.5. Spain
10.2.6. Rest of Europe

10.3 Asia-Pacific
10.3.1. China
10.3.2. Japan
10.3.3. India
10.3.4. Australia
10.3.5. South Korea
10.3.6. Rest of Asia-Pacific

10.4 South America
10.4.1. Brazil
10.4.2. Argentina
10.4.3. Rest of South America

10.5 Middle East & Africa
10.5.1. Kingdom of Saudi Arabia 
10.5.2. United Arab Emirates
10.5.3. Rest of Middle East & Africa

11. Company Profiles
11.1 Adobe Systems, Inc.
11.1.1. Company details 
11.1.2. Financial outlook
11.1.3. Product summary 
11.1.4. Recent developments

11.2 Verizon Communications Inc
11.2.1. Company details 
11.2.2. Financial outlook
11.2.3. Product summary 
11.2.4. Recent developments

11.3 Alphabet Inc.
11.3.1. Company details 
11.3.2. Financial outlook
11.3.3. Product summary 
11.3.4. Recent developments

11.4 Tencent Holdings Ltd.
11.4.1. Company details 
11.4.2. Financial outlook
11.4.3. Product summary 
11.4.4. Recent developments

11.5 Magnite Inc.
11.5.1. Company details 
11.5.2. Financial outlook
11.5.3. Product summary 
11.5.4. Recent developments

11.6 Amazon.com Inc.
11.6.1. Company details 
11.6.2. Financial outlook
11.6.3. Product summary 
11.6.4. Recent developments

11.7 AT&T Inc.
11.7.1. Company details 
11.7.2. Financial outlook
11.7.3. Product summary 
11.7.4. Recent developments

11.8 Alibaba Group Holdings Ltd.
11.8.1. Company details 
11.8.2. Financial outlook
11.8.3. Product summary 
11.8.4. Recent developments

11.9 ECHO Marketing, Inc.
11.9.1. Company details 
11.9.2. Financial outlook
11.9.3. Product summary 
11.9.4. Recent developments

11.10 Roku Inc.
11.10.1. Company details 
11.10.2. Financial outlook
11.10.3. Product summary 
11.10.4. Recent developments

SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.

The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings.  The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.

SPER-Methodology-1

SPER-Methodology-2

SPER-Methodology-3


Frequently Asked Questions About This Report
The Anesthesia Drug Market is projected to reach USD 3.09 billion by 2032, growing at a CAGR of 3.7% during the forecast period.
The Anesthesia Drug Market grew in market size from 2021. The Market is expected to reach USD 3.09 billion by 2032, at a CAGR of 3.7% during the forecast period.
The Anesthesia Drug Market CAGR of 3.7% during the forecast period.
You can get the sample pages by clicking the link - Click Here
The Anesthesia Drug Market size is USD 3.09 billion from 2022 to 2032.
The Anesthesia Drug Market segment is Covered By Drug Type, By Route of Administration, By Surgery Type, By End User.
The North America region is anticipated to have the highest market share in the Anesthesia Drug Market.
More consumers are turning to internet shops to make purchases, pay bills, and consult with doctors. This shift in consumer behaviour is projected to propel the general anaesthetic pharmaceutical market in the coming years.
The key players in the market include Companies Covered Abbott Laboratories, Abbvie, Akorn, Apotex, Astra Zeneca Plc, Baxter International Inc., Bayer AG, F. Hoffmann- La Roche, Fresenius Se & Co KgaA, Gilead Science Inc., Galxo SmithKline Plc, Heritage Pharmaceutical Inc., Hikma Pharmaceuticals Plc, Merck & Co Inc., Novarits AG, Par Pharmaceuticals, Pfizer Inc., Piramal Enterprises Ltd., Sanofi, Teva Pharmaceuticals.
Not able to find what you are looking for? Need customization in the existing report?
Click Here
PLACE AN ORDER
  • 15% off
     
    $ 4250
  • 20% off
             
    $ 5650
  • 25% off
         
    $ 7450
Pre-Purchase Inquiry
SEND AN INQUIRY
NEED CUSTOMIZATION?
Request Customization
100% Secure Payment

SPER American Express
SPER VISA
SPER Master Card
SPER Mestro
SPER Paypal
SPER CCAvenues

Join SPER Panel

Our Global Clients

Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
SPER-Astellas Pharma
SPER-Citi Bank
SPER-Microsoft
SPER-EY
SPER-Sanofi
SPER-p&g
SPER-Johnson & Johnson
SPER-SIEMENS
SPER-LOREAL
SPER-Pfizer
SPER-IPSOS
SPER-Heineken
SPER-IQVIA
SPER-Kankar IMRB
SPER-Astellas Pharma
SPER-Citi Bank
SPER-Microsoft
SPER-EY
SPER-Sanofi
SPER-p&g
SPER-Johnson & Johnson
SPER-SIEMENS
SPER-LOREAL
SPER-Pfizer
SPER-IPSOS
SPER-Heineken
SPER-IQVIA
SPER-Kankar IMRB

SPER

Market Research

We are the leading, full-service global market research and consulting company.

Certificates
iso-1 iso-1
Secure Payments
SPER Payment Options
Connect with us